65 /100
HIGH RISK
Score updated May 30, 2026

ENSC — Ensysce Biosciences, Inc. Dilution Risk Tracker

Track ENSC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENSC — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
20
⚠️ Warrant Exposure
30
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split 70%
• 50-day avg $0.43 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 1.6 months cash remaining
📉 Score Deterioration 50%
• Score rose 46 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔔 Track ENSC — Get forecast alerts →

💹 Market Data

Market Cap$4.13M
Shares Outstanding14.69M
Float14.68M
Cash$745.5K
Debt$245.8K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 45.0% shares (2025Q4 vs prior)
17 institutional holders · 505.6K shares
#1 ADAGE CAPITAL PARTNERS GP, L.L.C. 149.7K shares
#2 DRW Securities, LLC 98.5K shares
#3 PERCEPTIVE ADVISORS LLC 86.7K shares
+ 14 more holders Sign up free to view →

📉 Short Interest

Short Interest814.6K
Days to Cover1.0
% of Float5.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ENSC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENSC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ENSC
📊 ENSC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ENSC Signal Convergence & Dark Pool Activity — StonkWhisper 📄 ENSC Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.